Journal of Pharmacological and Toxicological Methods

Papers
(The median citation count of Journal of Pharmacological and Toxicological Methods is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Development of simultaneous determination of dopamine 2, histamine 1, and muscarinic acetylcholine receptor occupancies by antipsychotics using liquid chromatography with tandem mass spectrometry29
Assessment of abuse liability and respiratory effects of mitragynine and 7-hydroxymitragynine in rats29
Overview of the bioanalytical methods used for the determination of benzodiazepines in biological samples and their suitability for emergency toxicological analysis25
Chronic bladder catheterization for precise urine collection in awake mice24
Comparison of cell viability methods for human mesenchymal/stromal stem cells and human A549 lung carcinoma cells after freeze-thaw stress22
Editorial Board20
Drug-target interaction prediction using reliable negative samples and effective feature selection methods15
A personal reflection on 23 years of the Journal of pharmacological and toxicological methods15
Predicting human cardiac QT alterations and pro-arrhythmic effects of compounds with a 3D beating heart-on-chip platform14
Organelle profiling of compound-induced effects in human iPSC-derived cardiomyocytes in combination with electrophysiology assays for in vitro prediction of cardiac safety14
Contractility assessment using aligned human iPSC-derived cardiomyocytes13
The impact of collaborative science on cardiovascular safety evaluation – A 10-year update of the HESI cardiac safety committee13
A retrospective analysis of the concordance between cardiovascular effects in telemetry studies, toxicity studies, and early clinical trials12
Metabolomics using high-resolution magic angle spinning nuclear magnetic resonance: Neurotoxicological applications11
Quantitative comparison of ECG limb lead configurations: Evaluating synonymity of interval measurements using alternative leads under appropriately controlled study conditions11
Off-target of a novel TYK2 inhibitor is associated with myocardial necrosis mediated by hemodynamic changes in rats10
In silico modelling of stroke volume, cardiac output and systemic vascular resistance in cardiovascular safety pharmacology studies by telemetry10
Corrigendum to ‘PolyCheck: A hybrid model for predicting polypharmacy-induced adverse drug reactions in tuberculosis treatment using heterogenous drug-target-ADR networks’ [Journal of pharmacological 10
Reproducible safety pharmacology echocardiography studies in vehicle-treated canines and NHPs10
Retrospective review of the safety pharmacology assessment of emerging therapeutic modalities approved from 2010 to 20239
hiPSC-derived neurons and multi-electrode array (MEA): Powerful tools within safety pharmacology for identifying the CNS modifying effects of compounds targeting ligand- and voltage-gated ion channels9
The visual field-testing maze and vision maze: Feasible techniques to evaluate visual field loss in animals9
Optimization of an method for assessing pulmonary permeability of inhaled drugs using alveolar epithelial cells9
Ciprofloxacin does not accelerate aortic stiffness or aortic dilation in healthy, hypertensive and diseased mouse models9
In-situ polyherbal gel as biomedicine in the management of Alzheimer's disease: Understanding ameliorative potential in Trimethyltin induced neurodegeneration8
Reevaluating safety pharmacology respiratory studies within the ICH S7A core battery: A multi-company evaluation of preclinical utility and clinical translation8
Effects of temperature, compound concentration verification, and internal fluoride on hERG8
Effect of telemetry study design on minimum detectable difference values for QTc interval8
Enhanced detection sensitivity in nonclinical cardiovascular telemetry studies: Impact of a characterized facility8
Enhanced interpretation of secondary pharmacology data through automated visualization tools to support safety assessment8
Less invasive, simultaneous, and continuous measurements of locomotor activity and body temperature using the nano tag® small accelerometer device in cynomolgus monkeys8
Investigation of in vitro I /hERG assays under physiological temperature conditions using the semi-automated patch-clamp system QPatch compact with temperature control system8
Development and validation of an LC-MSMS method for the quantitation of pacritinib; application of kinetics in rabbits7
Predicting clinical outcomes from off-target receptor interactions using Secondary Intelligence™7
Evaluation of the J-Tpeak and Tpeak-to-tend intervals of the ECG as proarrhythmia biomarkers in telemetered dogs7
Development of electrophysiological toxicity assay system with iPSC-derived GABAergic neurons generated by a rapid differentiation method7
Monitoring cardiomyocyte function with hybrid EFP-impedance technology for drug safety evaluation7
Comparisons of hERG data for 30 drugs generated by automated and manual patch clamp systems by the same laboratory7
An investigation into the relationship between acetazolamide systemic exposure, blood gas changes and ventilatory parameters in the sprague Dawley® rat7
Comparison of quinine-induced QRS prolongation in canine and primate telemetry studies: Applying concentration-effect modeling to assess ventricular conduction delay risk7
Analyzing atrial human iPSC-cardiomyocyte responses to GPCR and ion channel modulators: Introducing a chamber-specific cell model for preclinical testing7
Optimized J to T peak and T peak to T end measurements in nonclinical species administered moxifloxacin and amiodarone6
Diisopropylfluorophosphate (DFP) volatizes and cross-contaminates wells in a common 96-well plate format used in zebrafish larvae toxicology studies6
One step derivatization and dispersive liquid-liquid microextraction of hydroxychloroquine sulfate for its sensitive and accurate determination using GC–MS6
Lung physiology and controlled exposure study design6
Non-invasive monitoring of cardiac output: Validation in anesthetized laboratory rats by pharmacological beta-adrenergic pathway modulation6
Simulated traumatic brain injury in in-vitro mouse neuronal and brain endothelial cell culture models6
Development and validation of a sensitive LC-MS/MS assay for determination of upadacitinib in human plasma and its application in patients with inflammatory bowel disease6
Minimal requirements for stem-cells derived cardiomyocytes and MEA usage in view of field potential analysis by reverse modeling - A theoretical study on the impact of 3 variability factors5
Neural network emulation of the human ventricular cardiomyocyte action potential: A promising tool for more efficient computations in quantitative systems pharmacology studies5
Reference intervals and method sensitivity for electrocardiology, hemodynamics, and body temperature parameters in healthy cynomolgus monkeys5
The translation of hERG block and APD90 in vitro to clinical QTc prolongation in man5
Are current rat studies sensitive to detect blood pressure changes per the new FDA draft clinical blood pressure guidance?5
Taking a deep breath: Evidence-based approaches to respiratory safety assessment5
Gene therapy: A different challenge for toxicologists?5
Regulatory safety pharmacology & toxicology assessment studies: Measurement of the ECG and hemodynamic parameters in non-rodent species5
In silico modeling of hemodynamic and autonomic effects of a selective α2-adrenoceptor agonist in beagle dogs by telemetry5
In silico modeling of effects of pimobendan on cardiac output and systemic vascular resistance in beagle dogs by telemetry4
Meeting abstracts, Eighteenth Annual Themed Issue on Methods in Safety Pharmacology4
Protein malnutrition in BALB/C mice: A model mimicking clinical scenario of marasmic-kwashiorkor malnutrition4
Quantitative protein profiling of phenobarbital-induced drug metabolizing enzymes in rat liver by liquid chromatography mass spectrometry using formalin-fixed paraffin-embedded samples4
Using automated patch clamp for high throughput pharmacological characterization of cardiac action potentials4
Establishment of functional observational battery test in large animals (dogs and non-human primates)4
Computational modelling for improved translation of cardiac inotropic and lusitropic drug effects from rats to humans4
Establishment of high-throughput toxicity assay system with iPSC-derived GABAergic neurons generated by a rapid differentiation method4
In-house fabrication of bipolar electrode-cannula assembly for electrical stimulation and drug delivery at the same site in rat brain4
QT Ratio: A simple solution to individual QT correction4
Performance and feasibility of three different approaches for computer based semi-automated analysis of ventricular arrhythmias in telemetric long-term ECG in cynomolgus monkeys4
Recording of transcellular voltage deflections from cardiomyocytes on MEA devices using laser poration4
Improving on-tissue detection of doxorubicin by using matrix assisted laser desorption ionization mass spectrometry imaging4
Best practice considerations for nonclinical in vivo cardiovascular telemetry studies in non-rodent species: Delivering high quality QTc data to support ICH E14/S7B Q&As4
Serum starvation magnifies the delayed suppression of IK by probucol4
Editorial Board4
Reliable identification of cardiac conduction abnormalities in drug discovery using automated patch clamp II: Best practices for Nav1.5 peak current in a high throughput screening environment4
An in silico approach during safety pharmacology studies4
Evaluation of the head twitch response in male C57BL/6J mice as a measure of 5-HT receptor activation4
Ultra-fast UPLC–MS/MS approach for estimating X-376 in human liver microsomes: Evaluation of metabolic stability via in silico software and in vitro analysis4
Enhancing cardiac safety evaluation: Assessing drug interactions with the late Nav1.5 current3
A retrospective review of the effects of moxifloxacin in NHP at four different test sites3
Dog and minipig telemetry assay sensitivity to detect QTc prolongation: Moxifloxacin effects by timepoint and concentration-QTc relationship analysis3
Combining a systems immunology approach with in vitro data to evaluate drug-induced changes in the immune response after Influenza A Virus infection – A blueprint for the preclinical assessment of inf3
Virtual clinical QT exposure-response studies – A translational computational approach3
Assessing the cardiotoxicity of 31 compounds using a multiplexed kinetic image cytometry (KIC)-based assay: Harnessing the predictive power of human iPSC-cardiomyocytes for early drug development3
Effects of species of origin and mode of induction of microsomes on carbamazepine-induced cell toxicity3
Long-term monitoring of cardiac action potentials for the assessment of chronic cardiotoxicity3
Collaborative science in action: A 20 year perspective from the Health and Environmental Sciences Institute (HESI) Cardiac Safety Committee3
Development of a novel milli-fluidic liver tissue chip for mechanistic drug-induced liver injury (DILI) studies3
Cardiac 3D electromechanical tissue simulations for cardiac safety analysis3
Multi-site validation of in vivo QT ICH E14/S7B Q&A guidance in canines and non-human primates3
A general and rapid LC-MS/MS method for simultaneous determination of voriconazole, posaconazole, fluconazole, itraconazole and hydroxyitraconazole in IFI patients3
ICH E14/S7B Q&A integrated risk assessment: Strategies for managing TQT waivers if S7B non-clinical studies don't meet best practice expectations2
Therapeutic drug monitoring of busulfan and cyclophosphamide in hematologic malignancies: An LC-MS/MS development, validation and application2
Comparison of validity of standard nonclinical group size selection versus standard clinical group sizes for nonhuman primate QTc prolongation evaluation2
Evaluation of the translation of multiple cardiovascular regulatory mechanisms in the anesthetized dog2
In silico predictions of drug-induced changes on cardiac contractility in human ventricular cardiomyocytes2
Discovery and development of digital biomarkers to inform home-cage neuro-behavioral assessments in the rodent2
Stress-free blood sampling in minipigs: A novel method for assessing 24-h cortisol profiles and drug effects on diurnal and ultradian rhythms2
Elucidating the challenges with categorizing drugs that block cardiac sodium channels − The impact of temperature on drug-cardiac sodium channel interactions2
Editorial Board2
Variability of manual patch clamp hERG data generated using standardized protocols and following ICH S7B Q&A 2.1 best practices2
A calcium fluorescence assay for quantification of cholinergic receptor activity of clinical drugs in serum - comparison with radioactive methods2
Species comparison of compounds with known blood pressure effects in a vascular smooth muscle cell collagen contraction assay2
Editorial Board2
A translational study between human induced pluripotent stem cell-derived cardiomyocytes (Hipsc-Cm) and an in vivo model to predict proarrhythmogenic properties2
Correlation electrical repolarization and membrane hERG abundance in iPSC cardiomyocytes induced by chronic drugs actions on channel trafficking2
Validation of an LC–MS/MS method for quantitation of fostemsavir in plasma2
Study to compare effects of a positive inotrope administered concurrently with a beta-blocker in ventricular Tachy-Paced dogs in mild heart failure2
High-throughput evaluation of cardiac electrophysiology and predicted actions on cardiac ion channels using hiPSC-CM and MEA technology2
Safety pharmacology 2023 and implementation of the ICH E14/S7B Q&A guidance document2
Novel method for determination of colistin sulfate in human plasma by high-performance liquid chromatography-tandem mass spectrometry and its clinical applications in critically ill patients2
State-of-the-art in secondary pharmacology and its impact on the safety of new medicines2
Comparison of RPMI 2650 cell layers and excised sheep nasal epithelial tissues in terms of nasal drug delivery and immunocytochemistry properties2
Snapshot versus continuous analysis of respiratory parameters collected by whole body plethysmography following oral administration of caffeine and baclofen in conscious unrestrained rats1
Development of a pharmaceutical database to support the nonclinical evaluation of drug-induced cardiac toxicity1
A new approach for purification of the catalytic site of the angiotensin-conversion enzyme, N-domain, mediated by the ELP-Intein system1
Combination of quadrupole isotope dilution mass spectrometry with simultaneous derivatization and spray assisted droplet formation-liquid phase microextraction for the determination of methamphetamine1
The translation of QTc across species - Impact of subject number and exposure multiple tested on discriminatory sensitivity1
Electrocardiography and heart rate variability in Göttingen Minipigs: Impact of diurnal variation, lead placement, repeatability and streptozotocin-induced diabetes1
Editorial Board1
Spectrum of effects detected in the rat functional observational battery following administration of non-CNS targeted and CNS targeted compounds1
QTc least significant difference in stand-alone implanted telemetry safety pharmacology and jacketed external telemetry regulatory toxicology studies in dogs1
Non invasive jacketed telemetry in socially-housed rats for a combined assessment of respiratory system, electrocardiogram and activity using the DECRO system1
A retrospective review of the effects of moxifloxacin in dogs at four different test sites1
Chemometrics-assisted spectrophotometric method for the simultaneous determination of phenylephrine hydrochloride, chlorpheniramine maleate and paracetamol1
Chicken embryo as animal model to study drug distribution to the developing brain1
Inter-rater agreement between WHO- Uppsala Monitoring Centre system and Naranjo algorithm for causality assessment of adverse drug reactions1
Evaluating the proarrhythmic risk of delayed-action compounds in serum free cell culture conditions; serum-starvation accelerates/amplifies the effect of probucol on the KCNQ1 + KCNE1 channel1
Evaluation of laser optoporation-induced action-potential-like measurements on iPSC-cardiomyocytes and the assessment of drug-induced effects on APD and contractility1
Enhancing the functional maturity of hiPSC-derived cardiomyocytes to assess inotropic compounds1
Toxicology and safety pharmacology investigations on the nervous system: 2024 industry survey1
A comparative study of kidney lithogenic agents in Wistar rats by invasive and noninvasive methods1
Intravenous self-administration in the rat: Advantage of transcutaneous buttons for improving the animal welfare1
Editorial Board1
Identification of gene expression change associated with isoflurane anesthesia and neurocognitive disorders using bioinformatics methods1
Compound A, a novel dual mu and kappa opioid receptor agonist that exerts potent an analgesic effect comparable to oxycodone, showed no reinforcing effect in monkeys1
Thirty years of telemetry-based data acquisition for cardiovascular drug safety evaluation: Applications and optimization1
An evaluation of detection sensitivity and pharmacokinetic profile for conscious telemetered cynomolgus monkeys1
Cytochrome P450 3A4 (CYP3A4) protein quantification using capillary western blot technology and total protein normalization1
Current practices on the measurement of electrocardiogram and hemodynamic parameters in non–rodent species in regulatory safety assessment studies1
Nonclinical pharmacokinetics of E3112, a recombinant human hepatocyte growth factor, in rats and monkeys by a simple ELISA kit assay1
hERG block potencies for 5 positive control drugs obtained per ICH E14/S7B Q&As best practices: Impact of recording temperature and drug loss1
Drug combination assays using Caenorhabditis elegans as a model system1
Characterization of a human wearable ECG device for continuous in-cage data collection in non-rodents1
Fun with pharmacology: Evaluating stresses on the system using the core battery1
Importance of beating rate control for the analysis of drug effects on contractility in human induced pluripotent stem cell-derived cardiomyocytes1
A method for assessing and monitoring consistency of nonclinical ECG analysis1
The role of the central amygdala in threat response in a semi-natural environment1
Pharmacological assessments of NaV1.5 and hERG channel blockers in AV-ablated isolated rabbit heart assay under varying heart rates and temperatures1
Using cultured human myocardial tissue slices to test cardiotoxic effects1
Rodent models of anxiety and compulsion: When multiple endpoints add value1
Categorizing TdP risk with qNet: Effects of protocol design on HERG models and TMS outcomes1
Editorial Board1
Long-term inhibition of PI3K/Akt signaling by amiodarone augments late sodium current in CHO cells and hiPSC-CMs1
High-content cell imaging for chemical toxicity screening in the model organism Caenorhabditis elegans1
Improved translation of Nav1.5 channel inhibition to in vivo QRS interval prolongation via the hIPSC cardiomyocyte model1
Prediction of GABA receptor antagonist-induced convulsion in cynomolgus monkeys by combining machine learning and heart rate variability analysis1
Editorial Board1
Optimization of a method to detect levothyroxine and related compounds in serum and urine by liquid chromatography coupled to triple quadrupole mass spectrometry1
Lipopolysaccharide-induced abdominal nociception behavioral model in adult zebrafish (Danio rerio)1
Angiotensin II as a linking factor in cardiovascular disease enhanced cancer growth1
Molecular imaging of excitability difference between alkaloids/salts (nicotine, nicotinic benzoate, caffeine and arecoline hydrobromide)1
hERG agonists pose challenges to web-based machine learning methods for prediction of drug-hERG channel interaction1
Surgical instrumentation of cardiovascular telemetry device has minimal impact on the general toxicology data interpretation in Cynomolgus monkeys1
In vitro systems for the assessment of chronic cardiotoxic effects: News from the HESI stem cell working group1
A tiered approach to population-based in vitro testing for cardiotoxicity: Balancing estimates of potency and variability1
Preclinical nerve conduction: Nerve battery options for primate studies1
Test facility management: Responsibilities and paradigms of a new era1
A state-of-the-art method for high-throughput, automated locomotor activity testing in neuropharmacology, safety, and toxicology studies1
Cardiac injury miRNA profile in breast cancer patients treated with left-sided radiotherapy1
Best practice considerations for nonclinical in vivo cardiovascular telemetry studies with alternative study designs in non-rodent species1
Evaluation of the sensitivity/specificity of statistical analysis strategies for detecting moxifloxacin-induced QTc prolongation0
Association between gastrointestinal effects in rodent toxicity studies and decreased locomotor activity in rodent safety pharmacology studies0
Effects of high-fat diet and nutraceutical resveratrol on maximal force, power and fatigue resistance of skeletal muscle0
Exploratory continuous interstitial glucose monitoring using the FreeStyle Libre 2 device in cynomolgus monkeys0
Video-based detection of pentylenetetrazol induced severe convulsions in cynomolgus monkeys0
Compromising the immunogenicity of diphtheria toxin-based immunotoxins through epitope engineering: An in silico approach0
Regulatory feedback on drug discrimination studies for a small molecule with a novel mechanism of action0
Preclinical mitigation of 5-HT2B agonism-related cardiac valvulopathy revisited0
Cardiovascular effects of Zenalpha® compared to dexmedetomidine in ventricular tachy-paced dogs0
Physiologically relevant in vitro endothelial model for studying drug-induced vascular injury0
Adaptation of closed-chest infarction porcine model to adult Pannon minipigs0
Optimization of bioanalysis of dried blood samples0
Assay development and validation to measure contraction force from co-culture of human iPSC-derived cardiomyocytes and cardiac fibroblasts on the FLEXcyte 96 system0
Application for drug evaluation of human-induced pluripotent stem cell-derived cardiomyocytes cultured by anisotropic orientation0
Telemetry in toxicology studies – A comparison of data across species, technologies and time0
Chronic assessment of hERG trafficking on repolarisation and cytotoxicity in iPSC cardiomyocytes0
Intratracheal administration of solutions in mice; development and validation of an optimized method with improved efficacy, reproducibility and accuracy0
Revisiting the high-fat diet/low streptozotocin prediabetic rat model: A bioanalytical adjustment0
Analysis of baroreflex and heart rate variability – Tools in cardiovascular pre-clinical safety studies0
Functional observation battery (FOB)/Irwin integrated in general toxicology studies: A retrospective analysis0
Development of drug toxicity evaluation platform using hiPSC-derived cardiac organoids0
Understanding lymphatic drug delivery through chylomicron blockade: A retrospective and prospective analysis0
Variability of manual patch clamp data on Ca 1.2 and Na 1.5 channels generated using standardized protocols and following ICH S7B Q&A 2.1 best practices – Progress update of a HESI-coordinated mul0
A simple accurate method for concentration-QTc analysis in preclinical animal models0
Editorial Board0
Corrigendum to “Best practice considerations for nonclinical in vivo cardiovascular telemetry studies in non-rodent species: Delivering high quality QTc data to support ICH E14/S7B Q&As” [J. Pharm0
Contractility-based pharmacological characterization of hiPSC-derived atrial and ventricular cardiomyocytes assessed on the FLEXcyte 960
Innovative approaches to cardiovascular safety pharmacology assessment0
Intravenous self-administration – Valid experimental designs to evaluate the abuse potential of psychedelics, entactogens and drugs with novel mechanisms0
Standardizing high-throughput RNA extraction: Modifying commercial kits for improved purity, yield, and efficiency0
Evaluating mitochondrial dysfunction and hepatotoxicity in HUREL micro liver co-cultures0
Cardiovascular assessment of lipid nanoparticle-encapsulating mRNA therapeutics in rats using telemetry and Star-Oddi logger devices0
Development of a high-throughput system for advanced functional cell analysis to predict safety0
An iPSC-derived neurotoxicity screening platform demonstrates compound toxicity on calcium activity, synapses, viability and cell proliferation0
High throughput automated patch-clamp of cardiac ion channels using physiological fluoride-free internal solution0
Improving the in vivo QTc assay: Nonclinical concentration-QTc modeling for risk assessment0
Characterization of a human wearable ECG device for continuous data collection in freely moving non-rodents0
In vitro assessment of long-term cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes0
A characterization of aficamten, a cardiac myosin inhibitor, in core battery safety pharmacology studies0
Comparative toxicity assessment of selected nanoparticles using different experimental model organisms0
Advancing personalised treatment selection for atrial fibrillation: An in silico approach0
OCT2 in the heart and GAT1 in the brain: Functional characterization and drug development using SSM-based electrophysiology0
High-throughput drug screening of 3D hiPSC cardiac microtissues with inherited arrhythmia disorders to identify novel therapeutic compounds0
High-throughput assessment of cardiac safety via calcium and voltage imaging of 3D engineered heart tissues and 2D cell cultures using a novel instrumentation platform0
Improved seizure liability detection by combining rat hippocampal brain slice electrophysiology with in vivo behavior observation following intracerebroventricular drug administration0
The application of Bayesian forecasting to explore the effects of sex and high-fat diet on the pharmacokinetics of ropivacaine in the rat0
Artificial intelligence-based phenotypic characterization of gender-specific, patient – iPSC derived cardiomyocyte cell models0
Corrigendum to “The in vivo QTc core assay: An evaluation of QTc variability, detection sensitivity and implications for the improvement of conscious dog and non-human primate telemetry studies” [Jour0
From cellular waste to biomarkers; insights into past, present, and future methods to detect immune cell-derived extracellular vesicles using flow cytometry0
An optimized method for intratracheal instillation in mice0
Safety Pharmacology: Achieving a quarter century milestone as a scientific discipline0
Supporting an integrated QTc risk assessment using the hERG margin distributions for three positive control agents derived from multiple laboratories and on multiple occasions.0
Phenylthiourea-mediated experimental depigmentation reduces seizurogenic response of pentylenetetrazol in zebrafish larva0
A plug-and-play μFluidic adaptor: Transforming standard well plates into microphysiological systems to assess (pharmaco)kinetics in vitro0
Changes in the nerve conduction (NC) of juvenile rodents due to maturation with implications for preclinical evaluation of toxic neuropathies0
Amphetamine, methamphetamine, and MDMA in hair samples from a rehabilitation facility: Validation and applicability of HF-LPME-GC-MS0
Development of a label-free cytotoxicity assay for dose response analysis0
HERG block in HEK cells incorporated in real time into computer models of in silico cardiac repolarization using dynamic clamp0
Surgical instrumentation for concomitant systemic blood pressure and blood sampling in healthy rabbits0
Establishment of a new nonalcoholic steatohepatitis model; Ovariectomy exacerbates nonalcoholic steatohepatitis-like pathology in diabetic rats0
From neat compounds to complex mixtures: A potential screening strategy for cardiotoxic potential of botanicals0
A simple, accurate method for defining concentration-QTc in animals0
Panelizing secondary pharmacology profiling against key safety liabilities to further impact drug development0
The 2023 Safety Pharmacology Society (SPS) salary survey0
Editorial Board0
Simultaneous quantification of thalidomide, lenalidomide and pomadomide in plasma by LC-MS/MS0
Anticoagulant activity of Eucalyptus essential oils: An in vitro approach and a bioinformatics-based pharmacokinetic-pharmacodynamic analysis0
ICH S7B hERG and cardiac repolarization assays do not address mechanisms of QT prolongation for peptide and protein products0
Prediction of postural hypotension in humans from α -adrenoceptor binding data using secondary intelligence™0
Analysis of secondary pharmacology assays received by the US Food and Drug Administration0
A genetic algorithm-based approach for the prediction of metabolic drug-drug interactions involving CYP2C8 or CYP2B60
High-content analysis and Kinetic Image Cytometry identify toxicity and epigenetic effects of HIV antiretrovirals on human iPSC-neurons and primary neural precursor cells0
Improving the in Vivo QTc assay: The value of implementing best practices to support an integrated nonclinical-clinical QTc risk assessment and TQT substitute0
Editorial Board0
Concentration-QTc analysis in anaesthetized guinea-pigs as an early translational evaluation of ventricular repolarization and proarrhythmic risk assessment0
Comparison of electrocardiogram and blood pressure recording methods in non-rodent toxicology studies: A retrospective analysis0
Physiologic corrections for ECG intervals beyond QT0
Editorial Board0
Historical control data of nonclinical nerve conduction parameters in nonhuman primates0
Quantitative framework for using in vitro hERG IC s to support integrated nonclinical risk assessment for the new ICH E14/S7B Q&As0
0.15552020072937